178 related articles for article (PubMed ID: 25872341)
1. Leiomyosarcoma: a rare malignant transformation of a uterine leiomyoma.
Di Luigi G; D'Alfonso A; Patacchiola F; Di Stefano L; Palermo P; Carta G
Eur J Gynaecol Oncol; 2015; 36(1):84-7. PubMed ID: 25872341
[TBL] [Abstract][Full Text] [Related]
2. Malignant transformation of uterine leiomyomata.
Indraccolo U; Luchetti G; Indraccolo SR
Eur J Gynaecol Oncol; 2008; 29(5):543-4. PubMed ID: 19051832
[TBL] [Abstract][Full Text] [Related]
3. Leiomyosarcoma: a rare malignant change in a leiomyoma.
Jatoi N
J Coll Physicians Surg Pak; 2003 Feb; 13(2):106-7. PubMed ID: 12685956
[TBL] [Abstract][Full Text] [Related]
4. The selected biomarker analysis in 5 types of uterine smooth muscle tumors.
Zhang Q; Kanis MJ; Ubago J; Liu D; Scholtens DM; Strohl AE; Lurain JR; Shahabi S; Kong B; Wei JJ
Hum Pathol; 2018 Jun; 76():17-27. PubMed ID: 29258902
[TBL] [Abstract][Full Text] [Related]
5. Molecular and immunohistochemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas.
Mittal KR; Chen F; Wei JJ; Rijhvani K; Kurvathi R; Streck D; Dermody J; Toruner GA
Mod Pathol; 2009 Oct; 22(10):1303-11. PubMed ID: 19633649
[TBL] [Abstract][Full Text] [Related]
6. Use of X-chromosome inactivation pattern to determine the clonal origins of uterine leiomyoma and leiomyosarcoma.
Zhang P; Zhang C; Hao J; Sung CJ; Quddus MR; Steinhoff MM; Lawrence WD
Hum Pathol; 2006 Oct; 37(10):1350-6. PubMed ID: 16949924
[TBL] [Abstract][Full Text] [Related]
7. Expression of mucin-1, galectin-1 and galectin-3 in human leiomyosarcoma in comparison to leiomyoma and myometrium.
Weissenbacher T; Kuhn C; Mayr D; Pavlik R; Friese K; Scholz C; Jeschke U; Ditsch N; Dian D
Anticancer Res; 2011 Feb; 31(2):451-7. PubMed ID: 21378323
[TBL] [Abstract][Full Text] [Related]
8. Pleomorphic Undifferentiated Uterine Sarcoma in a Young Patient Presenting With Elevated Beta-hCG and Rare Variants of Benign Leiomyoma: A Case Report and Review of the Literature.
Krishnan V; Sauthier P; Provencher D; Rahimi K
Int J Gynecol Pathol; 2020 Jul; 39(4):362-366. PubMed ID: 31033798
[TBL] [Abstract][Full Text] [Related]
9. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma.
Leitao MM; Soslow RA; Nonaka D; Olshen AB; Aghajanian C; Sabbatini P; Dupont J; Hensley M; Sonoda Y; Barakat RR; Anderson S
Cancer; 2004 Sep; 101(6):1455-62. PubMed ID: 15316901
[TBL] [Abstract][Full Text] [Related]
10. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
Lieng M; Berner E; Busund B
J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521
[TBL] [Abstract][Full Text] [Related]
11. [Uterine leiomyosarcoma with subsequent pregnancy].
Friedrich M; Riffel B; Schillinger H; Schweizer J; Mink D; Reitnauer K; Helpap B; Schmidt W
Zentralbl Gynakol; 1998; 120(7):341-6. PubMed ID: 9703657
[TBL] [Abstract][Full Text] [Related]
12. Uterine smooth muscle tumours with hyperintense area on T
Ando T; Kato H; Furui T; Morishige KI; Goshima S; Matsuo M
Br J Radiol; 2018 Apr; 91(1084):20170767. PubMed ID: 29308922
[TBL] [Abstract][Full Text] [Related]
13. Leiomyosarcoma arising in a patient with prior mitotically active leiomyoma.
Kim JH; Choi YJ; Kim DC; Lee SJ
J Obstet Gynaecol Res; 2010 Feb; 36(1):187-90. PubMed ID: 20178549
[TBL] [Abstract][Full Text] [Related]
14. Neoplastic association of leiomyoma, bizarre leiomyoma and leiomyosarcoma uteri. Case report.
Tartagni M; Di Gesù G; Nicastri PL; Loizzi P
Eur J Gynaecol Oncol; 1994; 15(5):375-9. PubMed ID: 7828608
[TBL] [Abstract][Full Text] [Related]
15. [Uterine leiomyosarcomas: a surprising pathology. Review of the literature. Six case reports].
Durand-Réville M; Dufour P; Vinatier D; Martin de Lassalle E; Lucot JP; Monnier JC; Lecomte-Houcke M; Puech F
J Gynecol Obstet Biol Reprod (Paris); 1996; 25(7):710-5. PubMed ID: 8991905
[TBL] [Abstract][Full Text] [Related]
16. Malignant transformation of myomas: myth or reality?
Schwartz PE; Kelly MG
Obstet Gynecol Clin North Am; 2006 Mar; 33(1):183-98, xii. PubMed ID: 16504815
[TBL] [Abstract][Full Text] [Related]
17. Occult Leiomyosarcomas in a Canadian Province: A Retrospective Cohort Study.
Wu CQ; Woo LY; Giede KC; Thiel J; Karreman E; Rattray DD
J Obstet Gynaecol Can; 2019 Jan; 41(1):46-51. PubMed ID: 30341020
[TBL] [Abstract][Full Text] [Related]
18. Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study.
Raspagliesi F; Maltese G; Bogani G; Fucà G; Lepori S; De Iaco P; Perrone M; Scambia G; Cormio G; Bogliolo S; Bergamini A; Bifulco G; Casali PG; Lorusso D
Gynecol Oncol; 2017 Jan; 144(1):90-95. PubMed ID: 27817933
[TBL] [Abstract][Full Text] [Related]
19. Uterine Leiomyosarcoma: Can MRI Differentiate Leiomyosarcoma From Benign Leiomyoma Before Treatment?
DeMulder D; Ascher SM
AJR Am J Roentgenol; 2018 Dec; 211(6):1405-1415. PubMed ID: 30354268
[TBL] [Abstract][Full Text] [Related]
20. [Sarcomas and mixed mesodermal tumors of the uterus].
Günthert AR
Ther Umsch; 2011 Oct; 68(10):559-64. PubMed ID: 21968895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
